Skip to Content

'
Isaiah J. Fidler, DVM, PhD

Present Title & Affiliation

Primary Appointment

Director, Department of Cancer Biology, Cancer Metastasis Research Center, Houston, TX
R. E. "Bob" Smith Distinguished Chair in Cell Biology, Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Professor, Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Cancer Biology, Graduate School of Biomedical Sciences University of Texas Health Science Center, Houston, TX

Research Interests

 

Isaiah J. Fidler, D.V.M., Ph.D.

R. E. “Bob” Smith Distinguished Chair in Cell Biology

Professor of Cancer Biology and Urology

Director, Cancer Metastasis Research Center

 

Research in my laboratory continues to focus on the biology and therapy of cancer metastasis.  Most recently, we have focused on the development and progression of brain metastasis.  A large number of cancer patients develop metastasis to the brain.  For untreated patients, the median survival is 1-2 months, and conventional radio-chemotherapy can extend the median survival to 4-6 months.  The outcome of metastasis in general and brain metastasis in particular depends on the interaction of specific metastatic cells with host factors in the organ microenvironment (the “seed and soil” principle). 

 

Histological examination of clinical specimens of human breast, lung, melanoma, and colon brain metastases demonstrates that the lesions are surrounded and infiltrated by activated astrocytes expressing glial fibrillary acidic protein (GFAP).  GFAP-positive astrocytes are also associated with experimental brain metastases produced in mice by lung, brain, melanoma, and colon cancers.  We isolated astrocytes from the brain of the “ImmortoMouse” and established the cells in culture.  Multiple in vitro studies conclude that astrocytes cocultured with tumor cells protect the tumor cells from chemotherapeutic agents (Taxol, VCR, VBL, 5-FU).  Establishment of a gap junction between astrocytes and tumor cells is required for this chemoprotection.  Coculture of tumor cells with other tumor cells or fibroblasts does not protect the cells from chemotherapeutic drugs.  Microarray experiments for cross-species hybridization (human tumor cells cocultured with mouse astrocytes or mouse fibroblasts) identified upregulation of survival genes in tumor cells cocultured with astrocytes, but not with fibroblasts.  Significantly, these survival genes were uniformly upregulated in different tumor cells (breast, lung) cocultured with astrocytes.

 

The role of astrocytes in physiology is to supply glucose and oxygen to neurons to assure their survival.  Unfortunately, tumor cells that can proliferate in the brain parenchyma exploit astrocytes for these same functions.  Since the development of metastases depends on the interactions of tumor cells with host factors, treatment of brain metastasis must be directed against both the tumor cells and the organ microenvironment.

 

 

Education & Training

Degree-Granting Education

1970 University of Pennsylvania, Philadelphia, PHD, Pathology
1963 Oklahoma State University, Stillwater, OK, DVM, Veterinary Medicine
1961 Oklahoma State University, Stillwater, OK, BS, Veterinary Medicine

Experience/Service

Military or Other Governmental Service

Israel Defense Force, 1/1955-1/1957

Selected Publications

Peer-Reviewed Original Research Articles

1. Kim SJ, Kim JS, Papadopoulos J, Kim SW, Maya M, Zhang F, He J, Fan D, Langley R, Fidler IJ. Circulating macrophages expressing CD31: implications for acute and chronic angiogenesis. American Journal of Pathology 174(5):1972-1980, 5/2009. PMID: 19349357.
2. Zhang C, Zhang F, Tsan R, Fidler IJ. Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. Cancer Res 69(3):828-835, 2/2009. e-Pub 1/2009. PMCID: PMC2633423.
3. Weihua Z, Tsan R, Huang WC, Wu Q, Chiu CH, Fidler IJ, Hung MC. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 13(5):385-93, 5/2008. PMCID: PMC2413063.
4. Weihua Z, Tsan R, Schroit AJ, Fidler IJ. Apoptotic cells initiate endothelial cell sprouting via electrostatic signaling. Cancer Res 65(24):11529-35, 12/2005. PMCID: PMC1404497.
5. Fidler IJ. The organ microenvironment and cancer metastasis. Differentiation 70(9-10):498-505, 12/2002. PMID: 12492492.
6. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 50(19):6130-8, 10/1990. PMID: 1698118.
7. Schackert G, Fidler IJ. Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals. Cancer Res 48(12):3478-84, 6/1988. PMID: 3370643.
8. Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Science 217(4564):998-1003, 9/1982. PMID: 7112116.
9. Talmadge JE, Wolman SR, Fidler IJ. Evidence for the clonal origin of spontaneous metastases. Science 217(4557):361-3, 7/1982. PMID: 6953592.
10. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 197(4306):893-5, 8/1977. PMID: 887927.
11. Fidler IJ. Selection of successive tumour lines for metastasis. Nat New Biol 242(118):148-9, 4/1973. PMID: 4512654.
12. Fidler IJ. Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst 45(4):773-82, 10/1970. PMID: 5513503.

Last updated: 9/8/2009